Evaluation of Cochlear Implantation in Unilateral or Asymmetric Hearing Loss in Children.

Recruiting N/A Interventional Study
Unilateral Hearing Loss Asymmetric Hearing Loss
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
4 – 6
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
36 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Today, unilateral hearing loss must be assessed and managed just as bilateral hearing loss is. It is recommended to consider the auditory difficulties caused by the loss of stereophonic hearing and to offer auditory rehabilitation as early as possible. Studies show that hearing devices can be effective in certain cases and for specific auditory modalities. The prognostic factors for successful hea…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Child aged 4 to 6 years at the time of inclusion * Using spoken French as the primary mode of communication * Diagnosed with unilateral or asymmetric hearing loss : Unilateral is defined by severe to profound hearing loss in the affected ear (thresholds \> 70 dB at ≥ 4 freque…
Contacts

Nathalie LOUNDON, MD, PhD

01 71 39 67 82

natalie.loundon@aphp.fr

CONTACT

Laure CHOUPEAUX, Project manager

01 44 38 17 11

laure.choupeaux@aphp.fr

CONTACT